Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Implantica AGIPLTF Revenue per Share is $ as of . 20. Among 756 Medical Devices & Instruments companies, Implantica AG ranks worse than 132275% on this metric.
Implantica AG's revenue per share for the
six
months ended in . 20 was $0.00.
Implantica AG does not have enough years/quarters to calculate the revenue per share for the trailing twelve months (TTM) ended in . 20.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Implantica AG's Revenue per Share or its related term are showing as below:
IPLTF's 3-Year Revenue Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.7 * Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Implantica AG Revenue per Share Related Terms
Implantica AG Revenue per Share Historical Data
* Premium members only.
The historical data trend for Implantica AG's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG Revenue per Share Chart
Implantica AG Annual Data
Trend
Revenue per Share
Implantica AG Semi-Annual Data
Revenue per Share
IPLTF vs : Revenue per Share Comparison
For the Medical Devices subindustry, Implantica AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Implantica AG PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where Implantica AG's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Implantica AG's Revenue Per Share for the fiscal year that ended in . 20 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG (IPLTF) has a Revenue per Share of $ as of . 20. Revenue per share equals the per-share value of a company's sales. View historical data on Implantica AG and its competitors. According to the industry distribution chart, Implantica AG ranks #999999 out of 756 companies in the Medical Devices & Instruments industry.
Is Implantica AG's Revenue per Share too high?
Implantica AG's current Revenue per Share is $. Based on the distribution chart, Implantica AG ranks #999999 out of 756 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Implantica AG's Revenue per Share compare to ?
According to the Medical Devices & Instruments industry distribution chart, Implantica AG ranks #999999 out of 756 companies for Revenue per Share. This places Implantica AG in the lower half of its industry. The industry median Revenue per Share is 3.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Medical Devices & Instruments company?
The median Revenue per Share among Medical Devices & Instruments companies is 3.70, based on 756 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Implantica AG and its competitors. For the Medical Devices & Instruments industry, the median Revenue per Share is 3.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Implantica AG's current Revenue per Share is $. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (IPLTF) has a current Revenue per Share of $. The current Revenue per Share is $. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Implantica AG (IPLTF), the current Revenue per Share is $ as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IPLTF has been successfully added to your 
